TY - JOUR
T1 - Congenital adrenal hyperplasia
T2 - Diagnosis, evaluation, and management
AU - Antal, Zoltan
AU - Zhou, Ping
PY - 2009/7
Y1 - 2009/7
N2 - • CAH represents a family of disorders of the cortisol synthesis pathway in which more than 90% of cases are caused by 21OHD. The hallmark of 21OHD is excessive androgen production that varies in degree among its different subtypes. • The severe classic form of CAH is the most common cause of ambiguous genitalia in a genetically female fetus. • Experimental treatment of mothers with dexamethasone in early gestation results in significantly less virilization in female fetuses affected with classic CAH. • Newborn screening has had an important impact on identifying the salt-wasting subtype in male infants and preventing adrenal crisis. • Lifelong treatment with steroids is required for most patients. • The consequences of the disease and complications of the treatment remain a challenge and require the involvement of multiple subspecialties. • As in many other diseases, gene therapy offers real hope for a cure for CAH.
AB - • CAH represents a family of disorders of the cortisol synthesis pathway in which more than 90% of cases are caused by 21OHD. The hallmark of 21OHD is excessive androgen production that varies in degree among its different subtypes. • The severe classic form of CAH is the most common cause of ambiguous genitalia in a genetically female fetus. • Experimental treatment of mothers with dexamethasone in early gestation results in significantly less virilization in female fetuses affected with classic CAH. • Newborn screening has had an important impact on identifying the salt-wasting subtype in male infants and preventing adrenal crisis. • Lifelong treatment with steroids is required for most patients. • The consequences of the disease and complications of the treatment remain a challenge and require the involvement of multiple subspecialties. • As in many other diseases, gene therapy offers real hope for a cure for CAH.
UR - http://www.scopus.com/inward/record.url?scp=69849114178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69849114178&partnerID=8YFLogxK
U2 - 10.1542/pir.30-7-e49
DO - 10.1542/pir.30-7-e49
M3 - Article
C2 - 19570920
AN - SCOPUS:69849114178
SN - 0191-9601
VL - 30
SP - e49-e57
JO - Pediatrics in review
JF - Pediatrics in review
IS - 7
ER -